Cytokinetics outlines $830M-$870M 2026 operating expense range while advancing MYQORZO Germany launch
Cytokinetics Inc. · PHARMACEUTICAL PREPARATIONS · Now $76.76
+1.3% in 7d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
-0.4%
7d
+1.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS